<SEC-DOCUMENT>0001193125-24-186674.txt : 20240729
<SEC-HEADER>0001193125-24-186674.hdr.sgml : 20240729
<ACCEPTANCE-DATETIME>20240729064630
ACCESSION NUMBER:		0001193125-24-186674
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240729
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240729
DATE AS OF CHANGE:		20240729

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Guardant Health, Inc.
		CENTRAL INDEX KEY:			0001576280
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				454139254
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38683
		FILM NUMBER:		241148790

	BUSINESS ADDRESS:	
		STREET 1:		3100 HANOVER STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		855-698-8887

	MAIL ADDRESS:	
		STREET 1:		3100 HANOVER STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d869952d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gh="http://guardanthealth.com/20240729" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-231">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-07-29_to_2024-07-29">0001576280</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="gh-20240729.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-07-29_to_2024-07-29"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001576280</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-29</xbrli:startDate> <xbrli:endDate>2024-07-29</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-242">8-K</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-07-29_to_2024-07-29" format="ixt:datemonthdayyearen" id="ixv-243">July 29, 2024</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-244">GUARDANT HEALTH, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-07-29_to_2024-07-29" format="ixt-sec:stateprovnameen" id="ixv-245">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-246">001-38683</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-247">45-4139254</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">incorporation or organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-248">3100 Hanover Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-249">Palo Alto</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-07-29_to_2024-07-29" format="ixt-sec:stateprovnameen" id="ixv-250">California</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-251">94304</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-252">855</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-253">698-8887</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, include area code)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-07-29_to_2024-07-29" format="ixt-sec:boolballotbox" id="ixv-254">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-07-29_to_2024-07-29" format="ixt-sec:boolballotbox" id="ixv-255">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-07-29_to_2024-07-29" format="ixt-sec:boolballotbox" id="ixv-256">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-07-29_to_2024-07-29" format="ixt-sec:boolballotbox" id="ixv-257">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-258">Common Stock, $0.00001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-259">GH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-07-29_to_2024-07-29" format="ixt-sec:exchnameen" id="ixv-260">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-07-29_to_2024-07-29" format="ixt-sec:boolballotbox" id="ixv-261">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On July&#160;29, 2024, Guardant Health, Inc. (the &#8220;Company&#8221;) issued a press release announcing that the U.S. Food and Drug Administration&#8217;s (the &#8220;FDA&#8221;) has approved the Company&#8217;s Shield blood test to screen for colorectal cancer in adults age 45 and older who are at average risk for the disease. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated by reference herein. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d869952dex991.htm">Press release of Guardant Health, Inc., dated July&#160;29, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">GUARDANT HEALTH, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: July&#160;29, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John G. Saia</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">John G. Saia</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Legal Officer and Corporate Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d869952dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g869952dsp1.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NEWS RELEASE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Guardant Health&#146;s Shield<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP> blood test approved by FDA as a primary screening option, clearing path
for Medicare reimbursement and a new era of colorectal cancer screening </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Shield is first blood test approved by FDA as a primary screening option for colorectal cancer and that
meets performance requirements for Medicare coverage</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Blood test offers easy, convenient and pleasant screening option with potential for improving colorectal
cancer screening rates </I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Guardant Health to host investor conference call and webcast Monday, July</I><I></I><I>&nbsp;29, at 8:30
a.m. ET / 5:30 a.m. PT </I> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PALO ALTO, Calif. (</B>July&nbsp;29, 2024) &#150; Guardant Health, Inc. (Nasdaq: GH), a leading
precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company&#146;s Shield<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> blood test for colorectal cancer (CRC) screening in adults age
45 and older who are at average risk for the disease. It is the first blood test to be approved by the FDA as a primary screening option for CRC, meaning healthcare providers can offer Shield in a manner similar to all
<FONT STYLE="white-space:nowrap">non-invasive</FONT> methods recommended in screening guidelines. Shield is also the first blood test for CRC screening that meets the requirements for Medicare
coverage.<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Colorectal cancer is the second-leading cause of cancer-related death in the U.S., even
though it is highly treatable if caught early.<SUP STYLE="font-size:75%; vertical-align:top">2 </SUP>The American Cancer Society estimates that more than 150,000 people will be diagnosed with CRC in 2024 and the disease will be responsible for more
than 53,000 deaths.<SUP STYLE="font-size:75%; vertical-align:top">3</SUP> More than three out of four individuals who die from CRC are not up to date with their screening.<SUP STYLE="font-size:75%; vertical-align:top">4</SUP> Early detection is
critical. When colon cancer is found at an early stage before it has spread, the five-year relative survival rate is 91%. If the cancer has spread to distant parts of the body, the five-year relative survival rate is 14%.<SUP
STYLE="font-size:75%; vertical-align:top">5</SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The CRC screening rate in the U.S. is only about 59%, which falls well below the National Colorectal
Cancer Roundtable&#146;s goal of 80% for eligible individuals.<SUP STYLE="font-size:75%; vertical-align:top">6</SUP> More than one out of three eligible Americans &#150; over 50&nbsp;million people &#150; do not complete CRC screening, often due to
the perception that other available options, such as colonoscopy or stool-based tests, are invasive, unpleasant or inconvenient.<SUP STYLE="font-size:75%; vertical-align:top">7</SUP> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The persistent gap in colorectal cancer screening rates shows that the existing screening options do not appeal to millions of people,&#148; said Daniel
Chung, MD, gastroenterologist at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. &#147;The FDA&#146;s approval of the Shield blood test marks a tremendous leap forward, offering a compelling new solution to close
this gap. This decision will help make screening tests more broadly accessible and propel blood-based testing and CRC screening into a new era. With increased screening rates and early cancer detection, many more lives can be saved.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Shield blood test is the result of over 10 years of research and development, including collaboration between Guardant Health and leading health
organizations globally. Since the commercial introduction of the LDT (laboratory developed test) version in May 2022, the overall adherence rate for the Shield test has been more than 90%, meaning more than 90% of patients who were prescribed the
test in a real-world clinical setting completed it.<SUP STYLE="font-size:75%; vertical-align:top">8</SUP> In contrast, studies show only <FONT STYLE="white-space:nowrap">28-71%</FONT> of patients who are prescribed other screening methods, such as
colonoscopy or a stool test, complete them.<SUP STYLE="font-size:75%; vertical-align:top"><FONT STYLE="white-space:nowrap">9-12</FONT></SUP> Primary care physicians can have patients complete a Shield test with a simple blood draw during a routine
office visit, providing a convenient and more pleasant alternative screening method that doesn&#146;t require the special preparation, dietary changes, time and discomfort associated with colonoscopy or the unpleasantness of handling stool. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g869952dsp1.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The FDA approval of the Shield test is a significant victory for patients and an important milestone in
Guardant Health&#146;s mission to conquer cancer with data. Shield can help improve colorectal cancer screening rates so we can detect more cancers at an early stage, when they are treatable,&#148; said AmirAli Talasaz, Guardant Health <FONT
STYLE="white-space:nowrap">co-CEO.</FONT> &#147;We are now getting ready to launch this test in the near future and are very excited to empower physicians with a viable blood-based screening option to tailor the screening regimen to the unique needs
of their patients.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The FDA decision follows a strong <U>recommendation for approval</U> by an Advisory Committee panel in May 2024. The approval
was based on results of <U>ECLIPSE</U>, a 20,000+-patient registrational study evaluating the performance of the test for detecting CRC in average-risk adults. Designed to reflect the diverse population of the U.S., the study was conducted at more
than 200 clinical trial sites in rural and urban communities across 37 states. Results from the study, published in the March&nbsp;14, 2024, issue of <U>The New England Journal of Medicine</U>, showed that Shield demonstrated 83% sensitivity for the
detection of CRC, with 90% specificity for advanced neoplasia. This performance is within range of current guideline-recommended <FONT STYLE="white-space:nowrap">non-invasive</FONT> screening methods, in which overall CRC sensitivity ranges from 74%
to 92%.<SUP STYLE="font-size:75%; vertical-align:top">13</SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;In addition to performance, a screening test&#146;s value should be measured by how
accessible it is, and how likely people are to use it,&#148; said Michael Sapienza, CEO of the Colorectal Cancer Alliance. &#147;Guardant Health&#146;s Shield test checks all three of these boxes and is truly a welcomed addition to the screening
options currently available. Giving people choice, and offering a blood test that can reach those in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">harder-to-screen</FONT></FONT> communities, will undoubtedly be a huge step
forward in our battle against colorectal cancer.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;This is a promising step toward making more convenient tools available to detect colorectal
cancer early while it is more easily treated,&#148; said William M. Grady, MD, a gastroenterologist at Fred Hutchinson Cancer Center. &#147;The test, which has an accuracy rate for colon cancer detection similar to stool tests used for early
detection of cancer, could offer an alternative for patients who may otherwise decline current screening options.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Most people in my situation
know we&#146;re supposed to get screened for colon cancer,&#148; said Dennis Barnes, a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">55-year-old</FONT></FONT> attorney whose physician had recommended a colonoscopy. But despite
his best intentions, he had never scheduled one. &#147;It&#146;s hard to find the time to schedule it if you have a busy life and a demanding job,&#148; he said. When his doctor told him about Shield, he agreed to have the blood test and was
fortunate to have the result come back normal. &#147;I realized I had taken quite a risk by waiting so long to screen. The Shield test is a much more pleasant way to screen, and the convenience of it makes getting screened pretty much a <FONT
STYLE="white-space:nowrap">no-brainer.&#148;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;I was in for a routine physical and my doctor asked when I had my last colonoscopy,&#148; said
John Gormly, a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">77-year-old</FONT></FONT> business executive in Newport Beach, California. &#147;I said it&#146;s been a long time, so he offered to give me the Shield blood test. A
few days later the result came back positive, so he referred me for a colonoscopy. It turned out I had stage II colon cancer. The tumor was removed, and I recovered very quickly. Thank God I had taken that blood test.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shield is available for eligible individuals by prescription through a doctor or other healthcare professional and is expected to be covered for eligible
Medicare beneficiaries. Commercial insurance coverage for patients eligible for CRC screening will continue to expand following anticipated future guideline inclusion by the American Cancer Society and the U.S. Preventive Services Task Force
(USPSTF). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g869952dsp1.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For complete product information about the Shield blood test for CRC screening, including full safety
information, visit <U>ShieldCancerScreen.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Webcast Details </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health will host an investor conference call and webcast Monday, July&nbsp;29, at 8:30 a.m. ET / 5:30 a.m. PT to discuss the FDA approval for Shield.
A link to live audio of the webcast will be available on the &#147;Investors&#148; section of the company website at <U>investors.guardanthealth.com</U> or directly at this <U>link</U>. The webcast will be archived and available for replay after the
event. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Shield </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shield is a <FONT
STYLE="white-space:nowrap">non-invasive,</FONT> blood-based screening test that detects alterations associated with colorectal cancer in the blood. It is intended as a screening test for individuals at average risk for the disease, age 45 or older,
and is not intended for individuals at high risk for colorectal cancer. The Shield test can be considered in a manner similar to guideline-recommended <FONT STYLE="white-space:nowrap">non-invasive</FONT> CRC screening options and can be completed
during any healthcare visit. A positive Shield result raises concern for the presence of colorectal cancer or advanced adenoma and the patient should be referred for colonoscopy evaluation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Guardant Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health is a leading
precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives
disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and
treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and <U>Facebook</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains
forward-looking statements within the meaning of federal securities laws, including statements regarding the potential utilities, values, benefits and advantages of Guardant Health&#146;s liquid biopsy tests or assays, which involve risks and
uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions, and
actual outcomes and results could differ materially from these statements due to a number of factors. These and additional risks and uncertainties that could affect Guardant Health&#146;s financial and operating results and cause actual results to
differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and
Results of Operation&#148; and elsewhere in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023, and any current and periodic reports filed with or furnished to the Securities and Exchange
Commission thereafter. The forward-looking statements in this press release are based on information available to Guardant Health as of the date hereof, and Guardant Health disclaims any obligation to update any forward-looking statements provided
to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Guardant
Health&#146;s views as of any date subsequent to the date of this press release. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g869952dsp1.jpg" ALT="LOGO" STYLE="width:1.79722in;height:0.434722in;">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>References </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. The Shield test meets performance requirements for Medicare coverage under NCD 210.3. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. American Cancer Society. Key Statistics for Colorectal Cancer. Accessed online May&nbsp;8, 2023.
<U><FONT STYLE="white-space:nowrap">https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html</FONT></U> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. American Cancer
Society. Cancer Facts&nbsp;&amp; Figures 2024. Atlanta: American Cancer Society; 2024. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. Doubeni, C, et al. Modifiable Failures in the Colorectal Cancer
Screening Process and Their Association with Risk of Death. Gastroenterology. 2019 Jan; 156(1): 63&#150;74.e6. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. American Society of Clinical Oncology.
Colorectal Cancer: Statistics. <U>https://www.cancer.net/cancer-types/colorectal-cancer/statistics#</U>. Accessed April&nbsp;23, 2024. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. American Cancer
Society National Colorectal Cancer Roundtable. 80% in Every Community. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">https://nccrt.org/our-impact/80-in-every-community/.</FONT></FONT></FONT>
Accessed February&nbsp;15, 2024. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. Rich T, Raymond V, Lang K. Where are we today? Efforts to understand strategies and barriers to physician issuance of
a recommendation for colorectal cancer screening: a systematic review. Gastroenterology. 2020;158(6 suppl 1):S-918. <FONT STYLE="white-space:nowrap">doi:10.1016/S0016-5085(20)32981-4.</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Raymond V, Foster G, Hong Y et al. Implementation of Blood-Based Colorectal Cancer Screening: Real-World Clinical Experience. ACG 2023 Annual Scientific
Meeting Abstracts. Vancouver, BC, Canada: American College of Gastroenterology. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. Denberg TD, Melhado TV, Coombes JM, et al. Predictors of nonadherence
to screening colonoscopy. J Gen Intern Med. <FONT STYLE="white-space:nowrap">2005;20(11):989-995.</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. Gellad ZF, Stechuchak KM, Fisher DA, et al.
Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. Am J Gastroenterol. 2011;106(6):1125-1134. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. Inadomi
JM, Vijan S, Janz NK, et al. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies. Arch Intern Med. <FONT STYLE="white-space:nowrap">2012;172(7):575-582.</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. Exact Sciences. Third quarter 2019 webcast and conference call. Updated October&nbsp;29, 2019. Accessed December&nbsp;17, 2021. https:/<U><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">investor.exactsciences.com/investor-relations/events-and-presentations/event-details/2019/Third-Quarter-2019-Webcast-Conference-Call/default.aspx</FONT></FONT></U> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. Chung DC, Gray DM, Singh H et al. A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening. <I>N Engl J Med</I> 2024;390:973-83. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zarak Khurshid </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investors@guardanthealth.com </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mike Weist </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">press@guardanthealth.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">317-371-0035</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>gh-20240729.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 7/29/2024 12:17:06 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:gh="http://guardanthealth.com/20240729"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://guardanthealth.com/20240729"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gh-20240729_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gh-20240729_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>gh-20240729_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 7/29/2024 12:17:06 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>gh-20240729_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 7/29/2024 12:17:06 PM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="gh-20240729.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g869952dsp1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g869952dsp1.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M-XTXUJM&496YHRIRLF[;*I!PJ1_NS2>J8QOC)X2M?B^_P7U&5M-\43^&-/\
M$^AR7,D:VFO0W,^IPW>GV;9!34K5-.\_R6R98G=H_P#4.*:R'&RR-9_2C[7!
MQQ$\/544^:BXQIN,YK_GW-SY>9?#))2^)"?$&!AGSX=JMT,;+#T\11<FE"M&
M4JD94X=JE-4^;E?Q1;<?A9K_ !7^(-M\*?A[XF^(%YIL^L6WAFTM[N73;:>.
MUGNEN-0M+ +'/*CK&5:[#DE6X0@#)%89)E<\YS3!Y73K1P\\7-P5247*,;0E
M.[BFF_AMH^IOGF:PR+*<;FM2C+$0P4%-TXR492O.,+*332MS7U70\9^(/[0_
MC;P%'KFK#X">+M:\&Z%ID&L2^,;7Q%H5MILVFOIEMJ-S=K;2QO<)';F>6%@4
M+%K9F P17OY7PME^8_5J/^LV%PV/Q%1THX65"NZBJ*I*$8\T5R7E926MDI)-
MW/GLUXLS'*UB:W^JV+Q.786G&J\7"OAXTW3]G&I*7*WSI0NXOW;WBVE8VOAE
M\;/'OQ U7P['>_ CQ;X2\+>(=/.IP>,M0U_0[W3+>RETF;5--GDM+8)<.EZ5
MMH(]J[E:\1F4*K8Y\WX>RW*Z&*=+B3"XW&82:IO"TZ->%1R514ZBYIKD7L_>
ME+751:1TY-Q'FF:5\)&KPQBL!@L7#VD<74KT)TU!TW4IMP@^=^T]V,=-')-V
M29]'U\H?7'Q_^TC&M[\5?V4M(OD#Z//\5-0U.X20@0G5=%TRTGT,.K##/Y\]
MQM!Z\C^*ON>$W[+)>-*U/2O#+H0BUNJ=6KRU;=O=2N? \7KVF=\#4*FN'EF<
MYR3V]I2H\U&__;S=CZ3\>>+K'P#X,\3>,M24O9^&M&OM5DA4[7N7M86:WM(V
MP<27%QY4"G& TPS7Y_BL1#"8:MB)_#0A*37HM%\W9?,_6^&,AQ7$W$.3</8)
M\N(SC%T<+&3U5-5)I3JM:7C2AS5)>46?SC^+O%VM>-?%>M^,=<NFGUK7=3GU
M2ZG4LH2663=%%;C.8K>")8X8D!_=QPQH.%%?D->O4Q%:IB*LKU*LG)OL^B79
M15DNR2/]9\BR/+N',ERW(,LHJEEV5X>&&I0:3YH05I3J=)3K2<JE5OXISDWN
M?NE^RI\6I_BY\)-*U35)#+XD\/3MX8\12L<M=WNGV]O+;:FW ^>[T^XM99#@
M#S_M 7Y0*_3<BQ[Q^ ISF[UJ+]E4?>44K2_[>BTWYW/\V?&W@6EP'QUC<%@8
M<F3YK!9C@(K:C1KSG&IAUY8>O"I3@O\ GTJ3>K9R=VD5A^W#I#6#;9=<_9_O
M3KT,?"NMAXM*Z?=3JO63]S%"K-_#&J]AC]0IMU/#RNJNV%SJ'L6^G/AOWD5Y
M=6EU9_,DTJ/B1A_9:/$Y'/VZ7_3O%)4Y2\^B;Z*Q'^V&$U'2/@SX1U29K?P?
MXS^./@G0O&1RR076CE[NZ33KN4$".WFN8(W);HULC#E*? S=&OGV.H14L=@,
MIQ=;"K=QJVC%SBOYHQ;M;NUU%QZE5P_#^ KR<<OS#.,'1Q>ME*E>4E3D_P"6
M4HJ]^L5V/JR_N;;PWH-[=VVFW,UGH.D7-S!I&B60ENY;;2[-Y8M-TC3H=@EN
M6B@6&WMDVAF,:+C(Q\;2A/%8FG3E5C&>(J1BZE65HJ5223G4F[VBF^:<G>RN
MV?;U9PP>&J3A1E*GA:4I1I487DXTX-JG2@K7DU'EA!6N[)6/F'2_VI/!&I>-
M?"&B:G\*/B[X6U_Q7J<7A7P]K7C#X>1Z#%YFH3P--:QZI>Z@)A9ADAGGC@$G
MRPJ[(=@KZZKP=F%'+\?7HYSEN+PV!IO$5Z6%QKK.U--1E[.$.7FU<8.5MVDU
M=GQM'C3+:N89?AJV29G@L5CZBPU"KBL"J"O-IRBJDY\RBK*4U&^D4VG9%C]C
MW'_"N/%N"/E^,'Q,'';_ (GI_IBEQUIFV!Z?\)>7?^HZ'P!_R*,?Y9KF7_J0
MRGK;*G[;7@YF(55_9\UYF9B%557QC*223P  ,DU6'7_&O\>EO_;5"R_[E2,0
MTO$7+^B61U__ %+/B/QW\2_@E\9?%?QV\2^/_&Z:/J5OIT7@?X&Q_P!E^(;X
M:5%X:N?[6B\5176DV%Q# -6\0V\8WB1)EMKN[C8;60U^@Y;E6?Y!@^&\)EF7
MNO2E-XO-_P!Y1A[5UX^R>&<:E2,I>QH2>EN5U%%K5,_.LRS;AWB'&\38S,\R
M6'JQIK!Y,O9UY^R6'E[58J,J=.48NMB(K6_,J;DFK-'U!J?Q7C^,7[#7C/Q;
M+*LFN0>![_0_%,0PKQ>(](-K;WTCH"?+%VAM[]%_ACOT'4''R-#)7D/B+EV!
MC%K#O&4ZV&?>A4O*"O\ W-:;\X,^QKYVL_\ #3,<=)KZS'!5*.)7\M>DHQF[
M=.=6J+^[-'GWAWXO_';XC:"O[.VA_#;P?X,UR;X6Z#:OK_BCQD;I;CP7K7A^
MVTW_ (271=*@TM#JA:PFRR6[W@MII1',A,3@>EB<CX<RK$?ZT8G-L5C\-',*
MTE1P^%4;8JE6E4^KU:DJC]E::T<E#GBN:+U1YF%S[B;-<,N$\+E&$R_%2RZC
M%U\3BW*^$JT(T_K%&E&DO:^X]5"4_9S?+-:,]2T+P7!\.OVA/V=? MM=R7\?
MA7X#>*]&^W2)Y;WDMG<VB7%UY09O)66?S9%C#-L5PN3MR?(Q&/EFG"_%68S@
MJ4L9G.%J\BVBI1J-1OI?E5DW97:O9'L8;+H91Q7PCED)NI' Y)BJ/.]')PE2
M3E;6W,[M*[LG;H?5WQ(\-:'XN\ ^+_#GB2""?1=4\/ZI!>_:%0I;JMI++'?(
MS\0W%K-''<1R@@QR0(X(*@U\7E.+Q&!S+ XK"2E'$4*U.4.6]V^9)QTW4TW&
M2ZIM=3[G-\'AL=E>/P>,A&6&KT*D9J25DN5M3UV<&E*+Z.*?0_-?Q%\:9=*_
M8R^#/@_5]>;1M<^*5NW@N\UJ=;F[GT?X?Z+KESI.M:W)!:K)<W$2Z)#86(1$
M=Y4NI2F60X_5\+D$:O'N?XZCA57PV2R^M1HKEC&IC:E*-2C13E:"?MG.H[M*
M/*KZ,_(,5Q#*AX>\.Y?6Q3H8G.X_5)5GS2E2P-*K*G6KN,4YM*BH4U9-RYG;
M5'0_ _XI?!KP1^T1!X.^$?B.&]^&WQ5\,Z-IIL#I^KZ7'H/Q"\,69L+"0)JU
MA;!O[:T^ AWBWM->W@WXVH#R\09/GN8<+2QV=X5T\VR7$59\_/3J.M@<1+GF
MKTYSM]7J/1.W+26G4[.',YR#+>+(X#(L6IY/GF'I4^3DJTU1Q^&AR0=JD(7^
MLTUJXWYJKUZ'7_%'X5V'Q:_:M\3Z%)J%UH6O:5\"/#WB'P;XGL))([[PUXJT
MSQI,=,U2+RG4RQ*99(Y8L@M'*VQDD5'3BR?.:F1\&8+$JE'$8:MG&(H8K#S2
M<*^&GA(>TI.^ST3C+I)*]U=/NSK)*6>\;XW"NK+"XJADN'KX3$4VU/#8FGBY
M^SJQMNE=QE'K%NUG9K/^)OQ<UCQ5^SA\;?AM\2K*+0/C+X!T/2X/$VF+A+3Q
M'IB^(M$CLO&GAT[56YTF]1X7D$0Q#+.HVHDT2UKD^1T,%Q7P[FV4U'B<@S*O
M-X>IO*A4]C5<\)7WY:M)W2O\<5?5ILQSG/:^-X0XDR?.*:PO$.5T*<<136D*
M]/VU)0QE#;FI559RMI"3MHG%'TG\=?\ DUWXA?\ 9*+W_P!,:5\GPY_R6&5_
M]C&'_IX^PXF_Y(O-O^Q9/_TR>B?!W_DD?PM_[)WX*_\ 4;TVO*SS_D=9Q_V&
MXK_T_4/6R#_D19+_ -@.$_\ 4>F>CUY9ZQ\V?M2> M?\7?#VRU_P7"T_COX7
M>)=)^(WA*WC#-+?WGA]WDO-+1(R&F:YL'G*0C_6S6\$?\>1]7P=F6%P.:5,+
MCY<N6YQ0J8'$R>T(UDE"H^W)-1N_LQ<GT/D.-,LQ6.RJGBLNCS9GDN(I8_"Q
M6\YT&W.DN_/3<DDOBDHKJ68=:\+?M4? 768?#FHQVJ^+M!ETR\MY6\RZ\,>)
MX$ANAIVK0)AU>TU.&W9A@>=!MECRDJ$_/\4<.XO+ZN.R;&+DE*+5*K;W*L&[
MTJT']J$K)NVSO%ZIGZ!X6<?X7+L[X9XUP,/K$,KQ5.KB,-=*I&R=/%8:5[<M
M7V4ZD8.5E=QG\+1^,6N?L^?&CP_X@D\-77PW\6W.H+<M;P2Z7HFH:IIMX!(8
MTN+/4[&WDMI[9AAA() %4_.%(('XS4RK,:-5T98.JYIV7+"4HOSC**<6O._K
M8_U,R[Q1\/,RRN&;X?B_*Z.$E352<<3BZ.&Q%'2[A6PU6<:T*D=G'D=VO<<D
MTW^M_P"S#\,V_9W^#FJ7WQ#O[+1+^_NKGQ;XH>ZNXA9>'K&"R@M[:RN+I28V
MFAMK<R2F,N/-NFB0R;%9_P!%X9R?%4*%/"1I2JXW&54U2@N:7,THP@DMVDKM
MK1-O6RN?P+X^^)&4\:\52S++ZRAP]P]A/JE'$U4Z:K*%2I6KXJTK2C3G.?+2
MC)*3IPC)Q4IN*R/V<EU#XI?$CXE?M*:A97%AH?B2&V\!?"ZWO86@NG\%:%<A
M[S5FC?F.._U.WBD5?X95O$!*!6;]4XJ]EDV591PG2J1J8G".6,S"4'>*Q=:-
MHTKK?V--V?DX/>]OY:X157.LWSCB^K3E2PV+4<%EL9JTG@Z$KRJV>WMJB37F
MIK:U_H?XL_#'0?B]X%UCP-X@>>UM[]8KBPU.TP+[1-8LG\[3=7L22/W]O. 2
MFY1)&\L3$+*37RV29OB<BS&AF.%2E*C>,Z<O@JTIKEJ4I_W91T\G:2U1]7GF
M387/LLKY9BFX0JVE"I#XZ-6#YJ=6':4)*_2ZO&]F>!:+XB_:Y^'MG%X9UOX9
M^&OC5%IT/V33?'&A^-M-\(:AJ5M H2UF\0:9KD3$ZBT87SI(%52P/S2L6E;Z
M7$87@C,IO%X;-L1D$JKYJF$K82>)A3D]9*C4HM>XG?E4M4NRT7S&&Q7'>54U
M@\3D^'XAC17+3QE'%PPM2I%:1=>E63]^UN9QT;OK)WD]7P5\,_BEXW^)>C?%
M_P".?]AZ*W@ZUOX/AS\,_#EX^J6/AV[U6%;?4->US5F BU+66MU\I/)W1C$<
MB^480C8YAFV3Y=E-?(N'?;5UCI0>.Q]>*ISK1IOFA1HTE=TZ2E[SYO>>J=[W
M-LNR?.LQSC#Y]Q+['#/+XSC@,OP\W5A0E47+.O6JM)5*SC[JY5RK1JW*D8VG
M>%/C9\!O$/C6/X:^"]'^*_PX\:>*=3\:6>AOXGL_"/B?PAK>ME'U:S6YU6*2
MSU+17GCB:$)B1%!SA@3-O5QN0<1X7+WFV/JY-FV7X>GA955AY8G#XFC1NJ4N
M6FU.G5C%VE>\7^6%' \1<,8O,(Y/EU+.\HS#$U,7"C]8AA<1A*U:SJPYJB=.
MI1<E>-K2CV[\CXB^%7[0?B]?'WQ-U*Q\.:/\3_%_@^W^%7@[PMI>NI+IOP\\
M#ZGJ*WGB75M1UV4(NJZ_*@N ALE^1KG>G $4'=A,YX8P+RS**52O7RC 8F68
MXK$5*+53&XNG3Y:%*%%-^RH)\J?M'=I/F[R\_%Y)Q7CEFF<5:>'P^<X_"QRW
M"8:G63IX#!U*G-B*U2NTO:UVN9I4U9-KE[1^PO 7@30OA_X,\,^"M'M83I_A
MK1[/2X97AC\VZ>WB'VF^G.TYN;JZ,UQ(>\D[GO7PV99EB<RQ^+Q]>;]KBZLJ
MC5W:-W[L5Y0C:,?)(^^RO+,-E67X/+</!*C@J4*4797ERJTIO^].5Y2\VSY1
M^(7P(\?Q:Q\?--^']AIUSX)^-W@@7LMA)J=IIW]B_$ZTE2"6:*UN"H^Q:K8B
M6:>=#_Q\2)O"I$"?M,IXCRSV/#%7,ZM2&8<.XQ14U3E/VN7RO))RC]NA.RA%
M[PO;5GPV;\,YJJW%-'*J5.>7<28)S<'4C3]CF4+1;49?8KPUG);3M?1';^/_
M ((>(=<^'WPRUCPC<6GA_P"-WPBT'P^?"VK&5#:75SI^E6=IK?A+5;A,+=:'
MJ BN(<L=BL^21%-.)/.ROB'"X7,\VP^.C+$\/9W6K+$4K>]&,ZDI4L32B_AK
M4;J2MJTK;J-O3S7AO%XG*\FQ& E'"<29#1H_5JM_<E*%*$:V%JR6DJ%:SB[W
M2>NB<KX'CSP_\>+CXD_"WXN>%/AWX>U'6M%^'FL>'_$WAK4_&-C8VNFZQK5U
M%+<QVFI)N^W6T?E%HI43YD=0X1\@=668KAN&4YSD>.S2O1P]?'4:^'KTL+*<
MJE*C&2BY4VX\DGS)23>C3M=:G)FF$XGEG&29]@,IH5L1AL!6H8C#U<7"G&G5
MK2BY*-1*7/&/*^5I:IJ]GH0^)- _:O\ C#IT_@SQ%:> ?@YX*UA#9>*-2T/6
M;KQ5XPO='EPE]INDLB+9VPNK<R0N[F%@DA&\J61WA,3P5D-6&/PE3&Y]CZ#Y
M\/3K488;"PJK6%2JN:4Y<CLU%75UMLTL7A>.<_HRR[%T\#P]EU=<F(J4*T\3
MBITGI.G2?+&G#GC>+D[-)[[I]+\+/@AJ&@_%7Q!XS\0Z596'ASPAX7T?X8?!
M?0TO(=2.G>#],C+:EKEYY;%(=5U.Z42$NJS@7=TDF05)Y,YXAI8G)<+@,+7G
M5Q6.Q%7,,UJN#I\^*F[4Z,;ZRIT8:*WNW4;;'9DG#E7"9WBLPQ5"%'!X##4L
MNRBBIJI[/"4U>I6E;2-6M-7=_>LY*6YW/Q_^%4GQ0^&^I:/H M]/\9Z-=V/B
MGP+J@\NU?3_%F@R_:],877EG[.LX$UHTA!$8N_,(/EBO.X9SF.39K1KXGFJX
M"O&>'QE/67/AJRY*BY>KCI-+=N-EN>GQ1DDLYRBMA\+RT<PP\H8G!5-(^SQ5
M!\])\WV5*SIM[)2OT.4\%>!?B(WQWB^*WBS2-/TNWU+X%:!X2UB*TU2TO#:^
M-+?74U+5;.VC@8M+IZCS6CN0 I4HOWLA>W,,QRN/#?\ 8N"KSK3H9O7Q-)RI
MRAS865%4Z4VY;3=DI0W3N]CAR[+,V_UF6=X[#PH0K9-A\+54:D9\N+C7=2K"
M*CO!7;C/9JRW*_[47[.=E\=/"4LVC2QZ/\1-$LKB/P]K D:VCU.S<^;<>&-;
MFBYETFZD7*,X;[/.1* 4>9)JX/XJJ<.8V,:Z=;*Z\XNM2M=TYK2.(I)[58+1
MVMSPO&]^5J.-.$J?$N!<L.U0S;#0DJ%6_*JD'K+#5FMZ4VM+WY)VDE;F4O1/
MBCX.UWQ3\#?%W@71X(9/$6L> KG0+*WEN8H(&U*73%M5C>ZD(CCC\T$>82%Q
MSG%>7DV.PV"XBP&8UY..%P^,C6G)1;DJ:J<S:BM6[=-SU<ZR_$XWAK'Y9AXQ
MEBZ^"E0A%R48^T=/E2<GHE?KL=A\.M&O_#?P^\"^'M4CCBU/0O!_AG1]1BBE
M6>*._P!,T6RLKN..9/EFC6X@D =>& !'!K@S2O3Q69YCB:+;HXC$UZM-M6?)
M.K*46T]4^5JZZ'H93AZN#RO+<+62C6PN%P]*HD[I3ITH0DDUHTI)V:W.RKA/
M0"@#Y1\:?LXZI9>+;[XE? ;QI)\*O&^J,9?$.EO:#4/ ?C"7>9#)K>A[66TO
M'=I"UU!%-\TCR+"LTCRO]IE_%5&>"I91Q)EZSG+J&E"HI>SQF%6UJ-;>4596
MA)I627-RI17P^8\(UZ6.JYQPQF+R/,J[O7IN/M,%BGWK4-HS>MZD$W>[45)N
M3UK*3]L2"Q6&]L?V;KV_1-OVV/6_B9:0NX&!))9+X;DP2>2J3J.<#&*QG'@2
M4^:%7/:=/^3V& FUY*;Q,?O<#>$O$"%/EG1X?J5$K<_M\Q@GYN"PLON4U\CA
MG_9X^*?Q8U6TO/VDOB-I>K^%]/NH;RV^%GPVBU'2O!]Y<V[M)#)K.IWT-MJ&
MIQ*Q'[N6,R#'[NXB!96]"/%&3Y)1G3X4RJI0QE2+C+,<<X5,5!-6:HTX.5*D
MWW3MWC+=>:^%,ZSRO"IQ?FU.O@J,E..6Y>JE+"RE%W3K5)J-6JEV:OVG'8^Q
MK"PL=*L;/3-,M+;3].T^V@L[&QLX8[:TL[2VC6&WMK:")52&".)%144 *%
MXKX2I4J5JDZM6<JE6I)RG.3;E*3=W*3=VVWJV]V?H%*E3P].G1HTXT:5&*A"
M$4HQA&*M&,8JR2BE9):)%NH+"@ H * "@ H * "@ H * "@ H * "@ H * "
J@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm139874207084560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 29, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001576280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 29,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GUARDANT HEALTH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-4139254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3100 Hanover Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">698-8887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.00001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%
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M &3\<D9^]2X\NULD.57DE8J"D1SZJC=4H<P'>W_<L1>*)K;VYN_I4C967HO
M_0/&47M]@/MRE;O;MWA#LS4[NDMK$7J*YC?15XRI-OG@))._39E:VQS=@X+9
MV!K,:=:X[6\1/%IJ[L'QTA[5/U/[14T$6X&0=W$)AJUVI]]=P\B\/'$NI8'S
M:WFY812F@7T!GJ^D-!\->XBM_@<Q_@]02P,$%     @ SC7]6)^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ SC7]6 =!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " #.-?U8X,EOGO     K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " #.-?U8F5R<(Q &  "<)P  $P
M        @ '. 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( ,XU
M_5@I+T/B300  (\0   8              " @0\(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " #.-?U8GZ ;\+$"  #B#   #0
M        @ &2#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( ,XU_5B7BKL<
MP    !,"   +              "  6X/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( ,XU_5@<.&7J/P$  #P"   /              "  5<0  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " #.-?U8)!Z;HJT   #X 0  &@
M    @ '#$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" #.-?U899!YDAD!  #/ P  $P              @ &H$@  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  #R$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d869952d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d869952d8k.htm">d869952d8k.htm</File>
    <File>gh-20240729.xsd</File>
    <File>gh-20240729_lab.xml</File>
    <File>gh-20240729_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d869952d8k.htm": {
   "nsprefix": "gh",
   "nsuri": "http://guardanthealth.com/20240729",
   "dts": {
    "inline": {
     "local": [
      "d869952d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "gh-20240729.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gh-20240729_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gh-20240729_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-07-29_to_2024-07-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d869952d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-07-29_to_2024-07-29",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d869952d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://guardanthealth.com//20240729/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-24-186674-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-186674-xbrl.zip
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M)?6C?2L='I$.!^YV"0] V(IY#G-P-R+@_8&KJ,?$('#') #0!YVQ'B%J(-K
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M1958125&LDD<5Q4WUVMS(APL1SS7<C-VL5CTY.BL?WE]0@M0W;C+):!_-)V
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M7T4H\8%O3  W:'A8;&XQ+:#1X4:]Y@@ #=P42]WS6!KF7#YSM0*SDFBXN8W
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MDYL]]LN^!8@E_P!02P$"% ,4    " #.-?U8(ZX4R&X.   270  #@
M        @ $     9#@V.3DU,F0X:RYH=&U02P$"% ,4    " #.-?U8H=5:
M!"(;  #'6P  $0              @ &:#@  9#@V.3DU,F1E>#DY,2YH=&U0
M2P$"% ,4    " #.-?U8>41"(D,#  !-"P  #P              @ 'K*0
M9V@M,C R-# W,CDN>'-D4$L! A0#%     @ SC7]6%^$ZVA<!@  OT,  !,
M             ( !6RT  &=H+3(P,C0P-S(Y7VQA8BYX;6Q02P$"% ,4
M" #.-?U8D(NRJ+D$  !_*@  $P              @ 'H,P  9V@M,C R-# W
@,CE?<')E+GAM;%!+!08     !0 % #H!  #2.      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>d869952d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gh-20240729.xsd" xlink:type="simple"/>
    <context id="duration_2024-07-29_to_2024-07-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001576280</identifier>
        </entity>
        <period>
            <startDate>2024-07-29</startDate>
            <endDate>2024-07-29</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-231">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-07-29_to_2024-07-29"
      id="Hidden_dei_EntityCentralIndexKey">0001576280</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-242">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-243">2024-07-29</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-244">GUARDANT HEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-245">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-246">001-38683</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-247">45-4139254</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-248">3100 Hanover Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-249">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-250">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-251">94304</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-252">855</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-253">698-8887</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-254">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-255">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-256">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-257">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-258">Common Stock, $0.00001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-259">GH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-260">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-07-29_to_2024-07-29" id="ixv-261">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
